NG
PFE icon

Northstar Group’s Pfizer PFE Stock Holding History

Northstar Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$393K Sell
14,008
-223
-2% -$5.94K 0.06% 119
2025
Q4 		$354K Sell
14,231
-860
-6% -$21.7K 0.05% 123
2025
Q3 		$385K Sell
15,091
-105
-0.7% -$2.59K 0.06% 109
2025
Q2 		$368K Sell
15,196
-593
-4% -$13.8K 0.06% 112
2025
Q1 		$400K Buy
15,789
+513
+3% +$13.4K 0.06% 104
2024
Q4 		$405K Buy
15,276
+2,050
+15% +$55.6K 0.07% 102
2024
Q3 		$383K Sell
13,226
-4,172
-24% -$122K 0.07% 107
2024
Q2 		$487K Sell
17,398
-495
-3% -$13.6K 0.09% 85
2024
Q1 		$497K Hold
17,893
– – 0.1% 87
2023
Q4 		$515K Sell
17,893
-3,609
-17% -$109K 0.11% 82
2023
Q3 		$713K Sell
21,502
-236
-1% -$8.35K 0.17% 75
2023
Q2 		$797K Buy
21,738
+197
+0.9% +$7.67K 0.19% 72
2023
Q1 		$879K Buy
21,541
+426
+2% +$18.4K 0.23% 71
2022
Q4 		$1.08M Sell
21,115
-69
-0.3% -$3.31K 0.31% 60
2022
Q3 		$927K Sell
21,184
-119
-0.6% -$5.78K 0.28% 65
2022
Q2 		$1.12M Buy
21,303
+30
+0.1% +$1.53K 0.32% 63
2022
Q1 		$1.1M Sell
21,273
-335
-2% -$17.4K 0.26% 66
2021
Q4 		$1.27M Buy
21,608
+6,269
+41% +$311K 0.3% 62
2021
Q3 		$660K Buy
15,339
+248
+2% +$11K 0.17% 86
2021
Q2 		$591K Buy
15,091
+1,058
+8% +$41.1K 0.15% 92
2021
Q1 		$508K Buy
14,033
+216
+2% +$7.67K 0.14% 95
2020
Q4 		$509K Sell
13,817
-1,370
-9% -$50.3K 0.16% 89
2020
Q3 		$529K Buy
15,187
+1,903
+14% +$66.7K 0.18% 84
2020
Q2 		$412K Buy
13,284
+284
+2% +$9.65K 0.17% 88
2020
Q1 		$403K Buy
13,000
+66
+0.5% +$2.25K 0.18% 82
2019
Q4 		$481K Buy
12,934
+54
+0.4% +$1.92K 0.18% 87
2019
Q3 		$439K Buy
12,880
+58
+0.5% +$2.11K 0.18% 92
2019
Q2 		$527K Buy
12,822
+172
+1% +$6.83K 0.22% 79
2019
Q1 		$510K Buy
12,650
+149
+1% +$5.97K 0.23% 81
2018
Q4 		$518K Buy
12,501
+59
+0.5% +$2.45K 0.26% 77
2018
Q3 		$520K Buy
12,442
+2,069
+20% +$79.6K 0.24% 81
2018
Q2 		$357K Sell
10,373
-69
-0.7% -$2.36K 0.18% 94
2018
Q1 		$352K Buy
10,442
+36
+0.3% +$1.24K 0.18% 93
2017
Q4 		$358K Buy
10,406
+339
+3% +$11.6K 0.19% 92
2017
Q3 		$341K Buy
10,067
+1,000
+11% +$32.1K 0.2% 94
2017
Q2 		$289K Buy
9,067
+37
+0.4% +$1.17K 0.18% 97
2017
Q1 		$293K Sell
9,030
-648
-7% -$20.4K 0.19% 92
2016
Q4 		$298K Sell
9,678
-135
-1% -$4.12K 0.21% 87
2016
Q3 		$315K Sell
9,813
-94
-0.9% -$3.14K 0.23% 82
2016
Q2 		$331K Sell
9,907
-1,067
-10% -$34.1K 0.25% 77
2016
Q1 		$309K Sell
10,974
-170
-2% -$4.86K 0.24% 77
2015
Q4 		$341K Buy
11,144
+33
+0.3% +$1.04K 0.27% 73
2015
Q3 		$349K Buy
11,111
+31
+0.3% +$994 0.29% 74
2015
Q2 		$352K Buy
11,080
+31
+0.3% +$1.01K 0.27% 78
2015
Q1 		$365K Buy
11,049
+238
+2% +$7.57K 0.28% 78
2014
Q4 		$320K Buy
+10,811
New +$310K 0.25% 84

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northstar Group's PFE Position: Q1 2026 in Review

Northstar Group reduced its Pfizer (PFE) stake by 1.6% in Q1 2026, selling an estimated $5.94K and leaving 14,008 shares worth $393K. The position accounts for 0.06% of the portfolio, ranked #119.

Northstar Group first reported a position in PFE in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.27M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Northstar Group held 14,008 shares of Pfizer worth $393K as of Q1 2026.
  • Northstar Group sold 223 Pfizer shares in Q1 2026, an estimated $5.94K.
  • Pfizer made up 0.06% of Northstar Group's portfolio in Q1 2026, its #119 holding.
  • Northstar Group first reported a position in Pfizer in Q4 2014 and has held it in 46 quarters since.
  • Northstar Group's Pfizer position peaked at $1.27M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Northstar Group's 13F filing for Q1 2026, filed 28 Apr 2026.